Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2012/02/01
-
Journal
-
Indian UGC (journal)
-
Refrences32
-
Citations96
-
Jumpei Yamazaki
-
Rodolphe Taby
-
Aparna Vasanthakumar
-
Trisha Macrae
-
Kelly R. Ostler
-
Lanlan Shen
-
Hagop M. Kantarjian
-
Marcos R. Estecio
-
Jaroslav Jelinek
-
Lucy A. Godley
-
Jean-Pierre J. Issa
Cite
Yamazaki, Jumpei, et al. “Effects ofTET2mutations on DNA Methylation in Chronic Myelomonocytic Leukemia”. Epigenetics, vol. 7, no. 2, 2012, pp. 201-7, https://doi.org/10.4161/epi.7.2.19015.
Yamazaki, J., Taby, R., Vasanthakumar, A., Macrae, T., Ostler, K. R., Shen, L., Kantarjian, H. M., Estecio, M. R., Jelinek, J., Godley, L. A., & Issa, J.-P. J. (2012). Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics, 7(2), 201-207. https://doi.org/10.4161/epi.7.2.19015
Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, et al. Effects ofTET2mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics. 2012;7(2):201-7.
Journal Categories
Science
Biology (General)
Science
Biology (General)
Genetics
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Restoration of absent in melanoma 2 (AIM2) induces G2/M cell cycle arrest and promotes invasion of colorectal cancer cells | International Journal of Cancer |
| 64 | 2010 |
| Sensitive and quantitative universal Pyrosequencing™ methylation analysis of CpG sites | BioTechniques |
| 350 | 2003 |
| 10.1182/blood.V89.6.2079 | 1997 | |||
| Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification | Nature |
| 1,782 | 2010 |
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1 | Science |
| 3,901 | 2009 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management | American Journal of Hematology |
| 2024 | |
| Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies | Chemico-Biological Interactions |
| 1 | 2024 |
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies | Signal Transduction and Targeted Therapy |
| 17 | 2023 |
Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management | American Journal of Hematology |
| 34 | 2022 |
| Novel Germline TET2 Mutations in Two Unrelated Patients with Autoimmune Lymphoproliferative Syndrome-Like Phenotype and Hematologic Malignancy | Journal of Clinical Immunology |
| 2 | 2022 |
Citations Analysis
The category
Medicine: Medicine (General) 51
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Interpreting new molecular genetics in myelodysplastic syndromes and was published in 2012. The most recent citation comes from a 2024 study titled Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management. This article reached its peak citation in 2013, with 16 citations. It has been cited in 71 different journals, 25% of which are open access. Among related journals, the American Journal of Hematology cited this research the most, with 5 citations. The chart below illustrates the annual citation trends for this article.